Patients on TRT or Hormone Optimization Programs Men on testosterone replacement therapy who carry significant excess body fat face a compound problem: elevated adipose tissue increases aromatase activity, converting more testosterone to estrogen, undermining the hormonal optimization they're investing in
These include the glucagon receptor, GLP-1 pathways, and GIP signalling
As for the cost of Retatrutide, it is anticipated to parallel that of existing GLP-1 agonists like Wegovy and Zepbound, ranging between $1,000 to $1,500 per month without insurance
Four of the 6 (66.7%) RCTs were classified as having high RoB, and 2 (33.3%) were classified as having low RoB
Additionally, Semaglutide GLP-1 supports balanced blood sugar levels by enhancing insulin secretion in response to elevated glucose levels and suppressing glucagon release
Researchers have documented the safety profile observed in published Phase 2 research as predominantly gastrointestinal effects (nausea, diarrhoea, vomiting) typical of the incretin class, occurring most prominently during dose escalation and tending to decline with continued exposure (PMID 39515565, PMID 41785010)